| Jason Kelly |
Jason Kelly is the founder of Ginkgo Bioworks, Inc. and Ginkgo Bioworks Holdings, Inc., both founded in 2008. He held the title of Chief Executive Officer & Director at both companies. Currently, Dr. Kelly holds director positions at Gen9, Inc., Octant, Inc., and Motif Food Works, Inc. He previously held the position of Chief Executive Officer & Director at Soaring Eagle Acquisition Corp. and was an Independent Director at CM Life Sciences II, Inc. in 2021. Dr. Kelly received his undergraduate and doctorate degrees from the Massachusetts Institute of Technology. |
| Steven P. Coen |
Steven P. Coen is currently the Chief Accounting Officer at Ginkgo Bioworks Holdings, Inc. Prior to this, he was the Vice President & Controller at Charles River Laboratories International, Inc. from 2017 to 2023. He obtained his undergraduate degree from Bentley University. |
| Bartholomew Canton |
Bartholomew Canton founded Ginkgo Bioworks, Inc. in 2008, where he is working as Chief Technology Officer & Secretary from 2008 and Ginkgo Bioworks Holdings, Inc. in 2008, where he is working as Chief Technology Officer from 2008. Dr. Canton received his doctorate degree from Massachusetts Institute of Technology and graduate degree from University College Dublin. |
| Mark Dmytruk |
Mark Dmytruk is currently the Chief Financial Officer at Ginkgo Bioworks Holdings, Inc. He previously worked as a Manager at Ernst & Young LLP from 1993 to 1999, Vice President-Finance at Blueprint Genetics, Inc. from 2009 to 2011, Vice President-Corporate Development at Thermo Fisher Scientific, Inc. from 2001 to 2009, Chief of Staff at inVentiv Health, Inc. from 2014 to 2017, and Executive VP-Corporate Strategy & Development at Syneos Health, Inc. from 2017 to 2020. He is also currently the Chief Financial Officer at Soaring Eagle Acquisition Corp. Mr. Dmytruk received his undergraduate degree from the University of Alberta in 1993 and his MBA from MIT Sloan School of Management in 2001. |
| Marijn E. Dekkers |
Marijn E. Dekkers is the founder and currently holds the position of Chairman at Novalis Lifesciences LLC, which was founded in 2017. He is also currently serving as Chairman at AgBiome INC, Ginkgo Bioworks, Inc., eTheRNA immunotherapies NV, Unilever International Holdings NV, Ginkgo Bioworks Holdings, Inc., Georgetown University, Foundation for the National Institutes of Health, Inc., Enko Chem, Inc., Flywheel Exchange, Inc., Cerevel Therapeutics LLC, Q-SI Operations, Inc., Vizgen, Inc., Cerevel Therapeutics Holdings, Inc., Animol Discovery, Cerevel Therapeutics, Inc., The Business Roundtable, The Business Council, and Bundesverband der Deutschen Industrie e.V. He has previously held the position of Chairman-Management Board & CEO at Bayer AG from 2010 to 2016, Chief Executive Officer at Bayer HealthCare AG in 2010, President, Chief Executive Officer & Director at Thermo Fisher Scientific, Inc. from 2000 to 2009, Independent Director at GE Aerospace from 2012 to 2018, Director at Biogen, Inc. from 2007 to 2009, Non-Executive Director at Unilever Plc from 2016 to 2020, Independent Director at Quanterix Corp. from 2017 to 2021, Non-Executive Director at Unilever NV from 2016 to 2020, and President at Verband der Chemischen Industrie eV from 2011 to 2016. Dr. Dekkers has a graduate and doctorate degree from Technische Universiteit Eindhoven and an undergraduate degree from Radboud University Nijmegen. |
| Reshma Shetty |
Reshma Shetty is the founder of Ginkgo Bioworks, Inc. (founded in 2008) where she holds the titles of President, Chief Operating Officer & Director. She is also the founder of Ginkgo Bioworks Holdings, Inc. (founded in 2008) where she holds the titles of President, Chief Operating Officer & Director. Dr. Shetty's current jobs include being the President, Secretary & Director at Gen9, Inc. and the President, Secretary, Treasurer & Director at Motif Food Works, Inc. Dr. Shetty's former job was being the President, Chief Operating Officer & Director at Soaring Eagle Acquisition Corp. Dr. Shetty received her undergraduate degree from the University of Utah in 2002 and her doctorate degree from Massachusetts Institute of Technology in 2008. Dr. Shetty is also the founder of Petri. |
| Harry Evans Sloan |
Harry Evans Sloan founded SBS Broadcasting SA in 1990, where he worked as Executive Chairman from 2001 to 2005, Global Eagle Entertainment, Inc. in 2011, where he worked as Chairman & Chief Executive Officer from 2011 to 2013, Silver Eagle Acquisition Corp. in 2013, where he worked as Chairman & Chief Executive Officer from 2013 to 2015, and various other companies. Mr. Sloan also founded Sloan, Kuppin & Ament and Eagle Equity Partners II LLC, where he is working as Chairman & Chief Executive Officer. Mr. Sloan also currently works at DraftKings Holdings, Inc., as Vice Chairman from 2020, DraftKings, Inc., as Vice Chairman, Lions Gate Entertainment Corp., as Independent Director from 2021, and various other companies. Mr. Sloan also formerly worked at MGM Pictures, Inc., as Chairman & Chief Executive Officer, Metro-Goldwyn-Mayer Studios, Inc., as Non-Executive Chairman & Chief Executive Officer, New World Entertainment Corp., as Co-Chairman & Chief Executive Officer from 1983 to 1989, and various other companies. Mr. Sloan received his undergraduate degree in 1971 from the University of California, Los Angeles and graduate degree in 1976 from Loyola Law School. |
| Kathy A. Hopinkah Hannan |
Kathy A. Hopinkah Hannan is currently serving as the Chairman at the Smithsonian National Museum of The American Indian. She is also an Independent Director at Annaly Capital Management, Inc., Otis Elevator Co., Ginkgo Bioworks, Inc., Otis Worldwide Corp., Blue Trail Software Holding, Inc., and Ginkgo Bioworks Holdings, Inc. Additionally, she holds positions as a Trustee at Adler Planetarium & Astronomy Museum, The Conference Board, Inc., Committee for Economic Development, and the KPMG Foundation. She is a Member of Women Corporate Directors and a Member of Ho-Chunk Nation Wisconsin. In her former roles, Dr. Hannan served as the Chairman & National President at Girl Scouts of the USA from 2014 to 2020. She was also an Independent Director at Carpenter Technology Corp. from 2022 to 2023. She served as the Global Lead Partner at KPMG LLP from 2015 to 2018 and was the President of the National Advisory Council On Innovation & Entrepreneurship. She also served as an Independent Director at Anthropos Capital Corp.Dr. Hannan holds a doctorate degree from Benedictine University. She completed her undergraduate studies at Loras College, Georgetown University, and The University of Chicago Booth School of Business. |
| Reshma Kewalramani |
Reshma Kewalramani is currently the President, Chief Executive Officer & Director at Vertex Pharmaceuticals, Inc. She is also a Director at Biomedical Sciences Careers Program, Inc., Year Up, Inc., Ginkgo Bioworks, Inc., and Ginkgo Bioworks Holdings, Inc. Additionally, she serves as a Trustee at The General Hospital Corp. Previously, she was the Director at Kidney Health Initiative and an Independent Director at Soaring Eagle Acquisition Corp. Prior to her current roles, she worked at Amgen, Inc. as the VP-Global Clinical Development & Nephrology from 2004 to 2017. Dr. Kewalramani completed her undergraduate degree at Boston University and obtained a doctorate from Boston University School of Medicine in 1998. |
| Shyam Sankar |
Shyam Sankar is currently the Director at Ginkgo Bioworks, Inc. He is also an Independent Director at Ginkgo Bioworks Holdings, Inc. and the Chief Technology Officer & Executive VP at Palantir Technologies, Inc. Mr. Sankar previously served as an Independent Director at Soaring Eagle Acquisition Corp. and as the Vice President-Network Management at Xoom Corp. He holds a graduate degree from Stanford University and an undergraduate degree from Cornell University. |
| Arie S. Belldegrun |
Arie S. Belldegrun is the founder of several companies. He founded Bellco Capital LLC in 2004, Kite Pharma, Inc. in 2009, Agensys, Inc. in 1996, Kronos Bio, Inc. in 2017, Allogene Therapeutics, Inc. in 2017, VV Manager LLC in 2017, and IconOVir Bio, Inc. in 2020. Dr. Belldegrun is also the founder of 76Bio, Inc. Dr. Belldegrun currently holds positions at Breakthrough Services LLC, Two River Group Holdings LLC, Technology Assessment Group, Fosun Kite Biotechnology Co., Ltd., Breakthrough Properties LLC, UroGen Pharma Ltd., ByHeart, Inc., UCLA Institute of Urologic Oncology, Ginkgo Bioworks, Inc., 105 W First Street LLC, D3C1 Allston Co-Investment LP, Ginkgo Bioworks Holdings, Inc., and The American Association of Genitourinary Surgeons. Dr. Belldegrun's former positions include Equinor ASA, American Urological Association Education & Research, Inc., Arno Therapeutics, Inc., Cougar Biotechnology, Inc., Janssen Oncology, Inc., Soaring Eagle Acquisition Corp., Cell Design Labs, Inc., Email Real Estate.com, Inc., Paramount Acquisition Corp., Capricor Therapeutics, Inc., Talon Therapeutics, Inc., Sonablate Corp., Teva Pharmaceutical Industries Ltd., National Cancer Institute, Los Angeles Economy & Jobs Committee, and Bioscience for the State of California. Dr. Belldegrun's education includes a doctorate from The Hebrew University Hadassah Medical School and a graduate degree from Weizmann Institute of Science. |
| Christian O. Henry |
Christian O. Henry is currently the President, Chief Executive Officer & Director at Pacific Biosciences of California, Inc. He is also the Chairman at Wave Life Sciences Ltd. and a Director at Ginkgo Bioworks, Inc. Additionally, he holds the position of Independent Director at Wave Life Sciences USA, Inc. and Ginkgo Bioworks Holdings, Inc. In the past, Mr. Henry served as a Director at BlueGnome Ltd. from 2015 to 2017. He was also an Independent Director at Soaring Eagle Acquisition Corp. and CM Life Sciences III, Inc. Furthermore, he held the position of Vice President-Finance & Controller at Nektar Therapeutics from 1997 to 1999, and Vice President-Finance & Controller at Affymetrix, Inc. from 1999 to 2003. He served as the Chief Financial Officer at Tickets.com LLC from 2003 to 2005. Mr. Henry was the General Accounting Manager at Sugen, Inc. and a Senior Accountant at Ernst & Young LLP from 1992 to 1996. He also held the role of Senior Vice President & General Manager at Genomic Solutions, Inc. from 2012 to 2014. Lastly, he served as the Chief Commercial Officer & Executive VP at Illumina, Inc. from 2015 to 2017. Mr. Henry obtained an MBA from the University of California, Irvine in 1992. He also completed his undergraduate studies at the University of California San Diego in 1990. |
